Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Clinical Chemistry|March 11, 2004
Simple technique for internal control of real-time amplification assaysSiegfried Burggraf, Bernhard OlgemöllerActa Cytologica|August 25, 2009
Correlation of HPV16 L1 capsid protein expression in cervical dysplasia with HPV16 DNA concentration, HPV16 E6*I mRNA and histologic outcomeSiegfried Kösel, Siegfried Burggraf, Werner Engelhardt, et al.Clinical Chemistry and Laboratory Medicine|July 26, 2003
Type-specific detection of human papillomaviruses in a routine laboratory setting--improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisationSiegfried Kösel, Siegfried Burggraf, Jens Mommsen, et al.Dental Materials : Official Publication of the Academy of Dental Materials|March 21, 2022
Verification of lateral flow antigen tests for SARS-CoV-2 by qPCR directly from the test deviceLudwig Czibere, Siegfried Burggraf, Marc Becker, et al.Journal of Clinical Microbiology|April 9, 2005
Comparison of an internally controlled, large-volume LightCycler assay for detection of Mycobacterium tuberculosis in clinical samples with the COBAS AMPLICOR assaySiegfried Burggraf, Udo Reischl, Naeem Malik, et al.Dental Materials : Official Publication of the Academy of Dental Materials|February 8, 2021
Fast and cost-effective screening for SARS-CoV-2 variants in a routine diagnostic settingJürgen Durner, Siegfried Burggraf, Ludwig Czibere, et al.Clinical Chemistry|December 21, 2004
Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiencySiegfried Kösel, Siegfried Burggraf, Ralph Fingerhut, et al.Genes|November 27, 2024
A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn ScreeningJessica Bzdok, Ludwig Czibere, Siegfried Burggraf, et al.Journal of Neuromuscular Diseases|April 18, 2022
Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?Oliver Schwartz, Heike Kölbel, Astrid Blaschek, et al.Plos One|June 28, 2024
Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophyJessica Bzdok, Ludwig Czibere, Siegfried Burggraf, et al.Pageof 2